Xpert® MRSA NxG
Active MRSA surveillance testing in around 70 minutes
Sign in or create a MyCepheid account to add items to cart
Test pack size(s)
product image
10 Tests
GXMRSA-NXG-CE-10
Qty
Unit price
Subtotal
USD
Product is not available for purchase in your region.
Total
{{currency}}
0
Error adding items to cart. If this error persists, please contact Digital Support

The Need

  • Hospital-acquired methicillin-resistant Staphylococcus aureus (MRSA) infections are a major cause of morbidity and mortality worldwide1
  • People with methicillin-resistant Staphylococcus aureus (MRSA) infections are 64 % more likely to die than people with drug-sensitive infections2
  • Active surveillance of inpatients for MRSA is a strategy for preventing health care-acquired infections (HAIs) by MRSA1
1 Yarbrough M, et al. Multicenter evaluation of the Xpert MRSA NxG assay for detection of methicillin-resistant Staphylococcus aureus in Nasal Swabs. J Clin Microbiol. 2017 Dec;56(1).
2 World Health Organization. (n.d.). Antimicrobial resistance. World Health Organization. https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance

The Solution

  • Xpert® MRSA NxG is a qualitative in-vitro diagnostic test intended for the detection of methicillin-resistant S. aureus (MRSA) DNA directly from nasal swabs in patients at risk for nasal colonization*
  • Quickly identify MRSA-colonized patients who require contact precautions to reduce the risk of transmission and avoid costly outbreaks
* Xpert MRSA NxG was compared to a Reference Culture Method. See Package Insert for additional details.

The Impact

  • Rapid implementation of infection control measures and patient bed management1
  • Superior clinical performance compared to other commercial tests1
  • Minutes of hands-on time with results in about 1 hour on a random-access platform1
1 Yarbrough M, et al. Multicenter evaluation of the Xpert MRSA NxG assay for detection of methicillin-resistant Staphylococcus aureus in Nasal Swabs. J Clin Microbiol. 2017 Dec;56(1).